We are live on ! Find out more
PI

Pennant Investors Portfolio holdings

AUM $361M
1-Year Est. Return 134.26%
This Fund
S&P 500
This Quarter Est. Return
+13.79%
1 Year Est. Return
+134.26%
3 Year Est. Return
+359.01%
5 Year Est. Return
+289.76%
10 Year Est. Return
–
AUM
$350M
AUM Growth
-$32.3M
Cap. Flow
-$49.6M
Cap. Flow %
-14.16%
Top 10 Hldgs %
86.09%
Holding
47
New
1
Increased
6
Reduced
5
Closed
31

Top Buys

Rank Stock Value
1
AR icon
Antero Resources
AR
+$8.22M
2
ASML icon
ASML
ASML
+$5.81M
3
IREN icon
Iris Energy
IREN
+$4.32M
4
PRM icon
Perimeter Solutions
PRM
+$4.14M
5
VRT icon
Vertiv
VRT
+$3.73M

Top Sells

Rank Stock Value
1
TDG icon
TransDigm Group
TDG
+$16.9M
2
ODP
ODP
ODP
+$15.7M
3
MSFT icon
Microsoft
MSFT
+$12.4M
4
AMZN icon
Amazon
AMZN
+$10.6M
5
MU icon
Micron Technology
MU
+$9.47M

Sector Composition

Rank Sector Weight
1 Communication Services 23.69%
2 Technology 20.58%
3 Industrials 20.11%
4 Materials 10.37%
5 Consumer Discretionary 9.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CMPX icon
26
Compass Therapeutics
CMPX
$387M
– –
-199,000
Closed -$199K
ENTA icon
27
Enanta Pharmaceuticals
ENTA
$400M
– –
-35,100
Closed -$455K
ERAS icon
28
Erasca
ERAS
$6.39B
– –
-166,200
Closed -$392K
ETNB
29
DELISTED
89bio
ETNB
– –
-44,500
Closed -$356K
FATE icon
30
Fate Therapeutics
FATE
$326M
– –
-146,100
Closed -$479K
KYNB
31
Kyntra Bio
KYNB
$29.4M
– –
-30,736
Closed -$686K
IGMS
32
DELISTED
IGM Biosciences
IGMS
– –
-64,900
Closed -$446K
MCRB icon
33
Seres Therapeutics
MCRB
$48.9M
– –
-14,615
Closed -$212K
MGNX icon
34
MacroGenics
MGNX
$257M
– –
-43,800
Closed -$186K
NRIX icon
35
Nurix Therapeutics
NRIX
$2.65B
– –
-56,800
Closed -$1.19M
NVAX icon
36
Novavax
NVAX
$1.31B
– –
-60,300
Closed -$763K
ODP
37
DELISTED
ODP
ODP
– –
-400,000
Closed -$15.7M
QURE icon
38
uniQure
QURE
$3.22B
– –
-48,500
Closed -$217K
RCUS icon
39
Arcus Biosciences
RCUS
$3.64B
– –
-23,700
Closed -$361K
REPL icon
40
Replimune Group
REPL
$1.01B
– –
-30,500
Closed -$275K
RLAY icon
41
Relay Therapeutics
RLAY
$4.33B
– –
-42,400
Closed -$276K
SAGE
42
DELISTED
Sage Therapeutics
SAGE
– –
-17,500
Closed -$190K
TVTX icon
43
Travere Therapeutics
TVTX
$5.78B
– –
-55,800
Closed -$459K
ZNTL icon
44
Zentalis Pharmaceuticals
ZNTL
$302M
– –
-32,400
Closed -$133K
ZYME icon
45
Zymeworks
ZYME
$1.67B
– –
-38,700
Closed -$329K
KLRS
46
Kalaris Therapeutics
KLRS
$96.8M
– –
-9,378
Closed -$156K
GETR
47
DELISTED
Getaround, Inc.
GETR
– –
-1,348,153
Closed -$189K
1
2

Similar funds

BCC
Bridge City Capital Lake Oswego, Oregon $361M AUM 38.29% 1-Year Est. Return
PPG
Peak Planning Group Centennial, Colorado $361M AUM 22.01% 1-Year Est. Return
PWC
PYA Waltman Capital Knoxville, Tennessee $361M AUM 9.49% 1-Year Est. Return
MCM
Monimus Capital Management Woodbridge, New Jersey $361M AUM 21.17% 1-Year Est. Return
SWM
SK Wealth Management Providence, Rhode Island $360M AUM 14.81% 1-Year Est. Return
RA
RR Advisors Dallas, Texas $360M AUM 28.52% 1-Year Est. Return
WIP
WealthCare Investment Partners Portsmouth, Rhode Island $360M AUM 19.98% 1-Year Est. Return
A6
Anchor @ 65 Singapore $362M AUM 20.02% 1-Year Est. Return

Pennant Investors's Q3 2024 Portfolio in Review

As of Q3 2024, Pennant Investors held 47 positions worth $350M, down 8.4% from $383M the previous quarter. Its ten largest holdings account for 86% of the portfolio.

Pennant Investors withdrew a net $49.6M in Q3 2024, closing 31 positions and reducing 5 holdings. Its most notable exit was ODP, an estimated $15.7M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 24% of assets, up from 19% a quarter earlier, followed by Technology and Industrials.

Against the trend, Pennant Investors opened a new position in ASML worth $5.42M.

  • Pennant Investors's largest Q3 2024 buy was ASML: 6,500 shares worth $5.42M.
  • Pennant Investors added most to Antero Resources in Q3 2024, an estimated $8.22M increase.
  • Pennant Investors's biggest Q3 2024 reduction was TransDigm Group, cutting an estimated $16.9M.
  • Pennant Investors fully exited ODP in Q3 2024, selling an estimated $15.7M.
  • Pennant Investors's ten largest holdings make up 86% of its $350M portfolio in Q3 2024.
  • Pennant Investors opened 1 new position and closed 31 in Q3 2024.
  • Pennant Investors's portfolio value fell 8.4% quarter-over-quarter to $350M.

Based on Pennant Investors's 13F filing for Q3 2024, filed 14 Nov 2024.